ClinicalTrials.gg
RecruitingNCT07539831Updated Apr 21, 2026

Effects of Menstrual Cycle on Optic Nerve Sheath Diameter in Patients Undergoing Laparoscopic Gynecologic Surgery

An observational study in Menstrual Cycle, Optic Nerve Sheath Diameter and Postoperative Nausea and Vomiting, sponsored by Konya City Hospital. Recruiting at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2026-04-21.

Sponsored by Konya City Hospital · Observational

How we know

From the registry’s dates

  • Started Apr 2026; still recruiting 7 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
110
Ages
18 Years to 45 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 96 studies in Postoperative Nausea and Vomiting with a site in Turkey — 22 open to participants now, 23 under way, none of them phase 3. Postoperative Nausea and Vomiting · Turkey.

Planned enrollment
9th of 25
110 · median 100
Started
2026
with 11 others
Observational
25 of 96
9 open now
Primary completion
2027-03
later than 16 of 22 live
Registered
88th of 96
by date
Lead sponsor
4 of 96
Konya City Hospital

Among the 96 studies in Postoperative Nausea and Vomiting with a site in Turkey, this one is the 9th largest by planned enrollment of the 25 observational ones that give a count, is one of 12 that started in 2026, is one of 25 observational ones, reaches primary completion later than 16 of the 22 other live ones, and was the 88th registered.

Postoperative Nausea and Vomiting

638 studies on the registry are indexed under Postoperative Nausea and Vomiting; 110 are open to participants now.

Browse Postoperative Nausea and Vomiting studies →

Open to participants now

22 of the 96 studies in Postoperative Nausea and Vomiting with a site in Turkey are open now. Recruiting first, the newest first:

16 more — sign in →

All 22 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 66 Postoperative Nausea and Vomiting studies recruiting now, 22 (33%) set no upper age limit and 38 (58%) stop at 75 or younger; 15 take children under 18; 11 take healthy volunteers.

This study: 18 Years to 45 Years · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 96 studies in Postoperative Nausea and Vomiting with a site in Turkey, or all of them as a file.
02

Study summary

This observational study aims to evaluate the effect of menstrual cycle phase on optic nerve sheath diameter (ONSD) in women undergoing elective laparoscopic gynecologic surgery. Patients will be grouped according to menstrual cycle phase as follicular or luteal. ONSD measurements will be performed perioperatively, and postoperative nausea and vomiting as well as postoperative cognitive function will also be assessed. The study is designed to investigate whether hormonal variations during the menstrual cycle are associated with differences in intracranial pressure reflected by ONSD measurements and postoperative outcomes

03

Conditions studied

  • Menstrual Cycle
  • Optic Nerve Sheath Diameter
  • Postoperative Nausea and Vomiting

Keywords

  • Optic Nerve Sheath Diameter
  • Laparoscopic Gynecologic Surgery
  • Mini-Mental State Examination
  • Verbal Descriptive Scale
  • Follicular Phase
  • Luteal Phase
04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Women aged 18 to 45 years with ASA physical status I-II who are scheduled for elective laparoscopic gynecologic surgery at Konya City Hospital. Participants will be observed according to menstrual cycle phase (follicular or luteal phase).

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Female patients aged 18 to 45 years
  • Scheduled for elective laparoscopic gynecologic surgery
  • Menstrual cycle in the follicular phase or luteal phase
  • (ASA) physical status I-II

Exclusion criteria

Exclusion Criteria:

  • Irregular menstrual cycle (e.g., polycystic ovary syndrome, early menopause, hypothalamic amenorrhea)
  • Pregnancy or breastfeeding
  • Neurological disease associated with intracranial pressure changes
  • Glaucoma or another eye disease associated with high intraocular pressure
  • Previous brain surgery
  • Uncontrolled hypertension or severe cardiovascular disease
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
110 participants (estimated)
Patient registry
No

Groups and cohorts

  • Follicular Phase

    Women undergoing elective laparoscopic gynecologic surgery during the follicular phase of the menstrual cycle (approximately days 12-14). Perioperative optic nerve sheath diameter measurements will be performed, and postoperative nausea, vomiting, and cognitive function will be assessed.

  • Luteal Phase

    Women undergoing elective laparoscopic gynecologic surgery during the luteal phase of the menstrual cycle (approximately days 20-25). Perioperative optic nerve sheath diameter measurements will be performed, and postoperative nausea, vomiting, and cognitive function will be assessed.

06

What researchers measure

Primary outcomes

  1. Optic Nerve Sheath Diameter

    The primary outcome is the comparison of optic nerve sheath diameter (ONSD) between women in the follicular phase and those in the luteal phase of the menstrual cycle undergoing elective laparoscopic gynecologic surgery. ONSD will be measured ultrasonographically in the supine position. For each eye, three horizontal and three vertical measurements will be obtained and averaged.

    Time frame: Before induction of anesthesia, during surgery, and at the end of surgery

Secondary outcomes

  1. Postoperative Nausea and Vomiting

    Postoperative nausea and vomiting will be assessed using the Verbal Descriptive Scale (VDS) and compared between the follicular-phase and luteal-phase groups. The VDS categories are none, mild, moderate, vomiting once, and severe vomiting.

    Time frame: Within 24 hours after surgery

  2. Postoperative Cognitive Function

    Postoperative cognitive function will be assessed using the Mini-Mental State Examination (MMSE) and compared between the follicular-phase and luteal-phase groups.

    Time frame: Preoperative period and 24 hours after surgery

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Apr 2026 (actual). Primary completion is estimated for Mar 2027, 10 months after the start.

Of 52 non-industry observational studies under Postoperative Nausea and Vomiting, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 37. This study's planned 10 months is close to that.

Counting every sponsor, half of 52 studies reached it within 11 months; a quarter within 4 and three quarters within 37.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 7, 2026
First posted
Apr 20, 2026
StartActual
Apr 20, 2026
Primary completionEst.
Mar 3, 2027
CompletionEst.
Apr 5, 2027
Last update
Apr 21, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 21, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07539831
Lead sponsor
Konya City Hospital
Responsible party
Mahmut Sami TUTAR (Principal Investigator, Department of Anesthesiology and Reanimation, Konya City Hospital, Konya City Hospital) — Principal investigator
First posted
Apr 20, 2026
Start date
Apr 20, 2026
Primary completion
Mar 3, 2027 (estimated)
Completion
Apr 5, 2027 (estimated)
Last update
Apr 21, 2026

Study contacts

MAHMUT TUTAR, MD
Contact
masatu42@gmail.com
905552723704
MAHMUT TUTAR, md
Contact
MAHMUT TUTAR, MD
principal investigator · Konya City Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion